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ABSTRACT: The biodistribution proﬁle of a new dextrin
nanomagnetogel, which consists of γ-Fe2O3 superparamagnetic
nanoparticles loaded within a polymeric matrix of modiﬁed
dextrin, was studied in mice. The nanomagnetogel bear a
monomodal size distribution proﬁle (average diameter 110
nm) close to neutral surface charge and higher relaxivity (r2 =
215−248 mM−1 s−1 and r2/r1 = 13−11) than those of
commercial formulations (r2 = 160−177 mM−1 s−1 and r2/r1 =
4−7). Also, the observed blood half-lifeapproximately 4 h
is superior to that of similar commercially available
formulations, which remain for a few minutes in circulation.
PEGylation resulted in 1.7- and 1.2-fold lower accumulation in the liver and spleen, respectively, within the ﬁrst 24 h.
Noteworthy, a good correlation was obtained between the amount of polymer (quantiﬁed by scintigraphy) in the spleen, 48 h
after administration, and the amount of iron physically loaded through hydrophobic interactions (quantiﬁed by ICP) indicating
the absence of iron leakage from the polymeric matrix. This study provides evidence of the in vivo stability of a self-assembled
nanomagnetogel, a relevant feature which is seldom reported in the literature.
■ INTRODUCTION
Bioprobes have enormous potential for clinical diagnosis due to
enhanced detection and characterization of abnormal state of the
body. Superparamagnetic iron oxide nanoparticles (SPION)
have been extensively studied as magnetic resonance imaging
(MRI) contrast agents.1 SPION need to be coated in order to
allow formulation in aqueous solutions and to increase the
stability in vitro and in vivo.2 The coating should be nontoxic and
present high aﬃnity for the iron oxide core.3 Clinically approved
formulations consist on SPION coated with dextran or similar
carbohydrates.4 After intravenous administration, SPION can be
readily released if they are only weakly associated with the
dextran coating, leading to aggregation and precipitation of the
SPION under physiological conditions.5 Thus, stable incorpo-
ration of SPION within the nanocarrier is very important to
ensure that they reach the target site. When the mononuclear
phagocytic system is not the target, the opsonization and
phagocytosis of nanoparticles should be avoided and the blood
half-life should be long enough to allow accumulation on the
target site. Grafting poly(ethylene glycol) (PEG) onto the
surface of nanoparticles can decrease nanoparticle interactions
with blood proteins, avoiding their recognition by the phagocytic
system and thus increasing the circulation time.6
Magnetic properties, such as water proton relaxation rate
enhancement (R1,2) and superparamagnetic behavior, are
important features of SPION. These particles mainly produce
T2-relaxation eﬀects, resulting in negative contrast in T2-
weighted images, which is determined by the translational
diﬀusion of water molecules in the heterogeneous magnetic ﬁeld
surrounding the SPION.7 There are two major factors
determining signal enhancement by SPION: the iron oxide
core (size and density) and the coating (thickness and chemical
composition).3 Increasing the size of bare SPION can increase its
transverse relaxivity.8 However, large particles (diameter larger
than approximately 15 nm) easily aggregate in solution.9 A
strategy to increase transverse relaxivity, while preserving the
superparamagnetic properties, consists of clustering individual
SPION within a polymeric structure. Previous studies indicate
that clustering magnetic nanoparticles into polymeric micelles
results in enhanced transverse relaxivity.10 Pharmacokinetics and
organ/tissue distribution properties of nanocarriers are of great
interest to predict their ability to reach the target site. A critical
aspect of self-assembled nanosystems regards its stability after
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administration. Very little information is available in the literature
on this topic, which is addressed here, following up on previous
work by our group describing the production and character-
ization of the dextrin nanomagnetogel.11 In vivo quantiﬁcation of
the biodistribution of SPION-based nanogels using MRI is often
diﬃcult to perform due to artifacts from air/tissue (lungs) and
motion. Furthermore, using a T2* mapping as a quantitative
method can be time-consuming. However, having a dual
modality probe, combining single-photon emission computer-
ized tomography (SPECT) and MRI, quantiﬁcation of the
biodistribution can be obtained measuring gamma photons
emitted by radionuclides using SPECT instrumentation. To label
the nanomagnetogel with a radionuclide, aω-thiol functionalized
DOTA-monoamide type metal chelator (DOTA = 1,4,7,10-
tetraazacyclododecanetetraacetic acid) was used for covalent
functionalization (via Michael addition) of the dextrin, and
labeling (complexation) with the 111In3+ radioisotope. For the
sake of clarity, the term “nanoparticles” will be used for γ-Fe2O3
nanoparticles, “nanogels” for the polymeric matrix of dextrin, and
“nanomagnetogels” for nanogels loaded with γ-Fe2O3 nano-
particles.
■ RESULTS
Nanomagnetogel Characterization. The size distribution
of the nanomagnetogel with and without PEG 5000 was
determined by dynamic light scattering, before and after
DOTA coupling. As can be seen in Table 1, the decoration of
the nanomagnetogel does not have a signiﬁcant eﬀect on its
average diameter. The size distribution proﬁle exhibits a single
peak with a remarkably narrow polydispersity index (PdI).
A substantial reorganization takes place upon loading the
nanogel with the iron nanoparticles. The presence of iron
nanoparticles induces swelling of the hydrophobic nanodomains
within the nanogel leading to a larger average size (around 110
nm) and a monomodal size distribution proﬁle was obtained. A
schematic representation of the nanomagnetogel structure is
presented in Scheme 1.
The concentration of stabilized γ-Fe2O3 within the dextrin
polymer was 4.0 mM, irrespective of being pegylated or not, as
determined by atomic absorption spectroscopy.
The zeta potential of bare dextrin nanogels was previously
reported as −4.02 mV.6 Loading of SPIONs does not
signiﬁcantly change this value (−7.77 mV; pH 7.4), while the
grafted DOTA macrocycle is expected to display an overall
negative charge at pH 7.4. In fact, nanomagnetogel functionaliza-
tion with the DOTA-monoamide chelator leads to a shift of the
zeta potential into the negative region (−24.4 mV; pH 7.4), thus
conﬁrming the success of the reaction. After complexation of the
DOTAdex_SPION with cold (nonradioactive) InCl3, the zeta
potential value returns to a near neutral value (3.51 mV),
consistent with the formation of neutral In(DOTA)dex_SPION
complexes (Figure S1, Supporting Information).
The longitudinal (r1) and transverse (r2) relaxivities are good
in vitro measures of the ability of the contrast agent to selectively
reduce the relaxation times T1 (spin−lattice relaxation time) and
T2 (spin−spin relaxation time) of the water protons, respectively,
and thus of their eﬃciency as positive or negative MRI contrast
agents. The inverse relaxation times, Ri (= 1/Ti), vary linearly
with the Fe concentration, according to eq 1
= +R r R[Fe]1,2 1,2 01,2 (1)
where R01,2 are the inverse relaxation times of pure water.
Relaxivities r1 and r2 were calculated through the least-squares
curve ﬁtting of R1,2 = 1/T1,2 (s
−1) versus the iron concentration
(mMFe) according to eq 1 (Figure S2, Supporting Information).
Table 2 shows the calculated r1 and r2 relaxivities of the
dex_SPION and dexPEG_SPION prepared in this work. Both
formulations display higher r2, but lower r1 than similar
commercial formulations (ferumoxides and ferucarbotran).
Superparamagnetic behavior of the formulations was con-
ﬁrmed with a MIAplex magnetometer at room temperature. The
second derivative of the magnetization curves obtained for the
pegylated nanomagnetogel is not modiﬁed compared to the
unpegylated formulation. The absence of hysteresis loops
indicates that the formulations preserve their superparamagnetic
behavior (Figure S3, Supporting Information).14
Blood Clearance and Biodistribution.To evaluate the fate
of the 111In-labeled nanogels and nanomagnetogels in vivo, ex
vivo biodistribution studies were performed in wild-type mice,
focusing on blood clearance and accumulation in the main
excretory organs (liver, spleen, kidneys).
Among the 111In-labeled formulations studied, the smaller
unloaded [111In]DOTAdex nanogel showed signiﬁcantly higher
blood levels 1 h after injection, as compared to the larger SPION
Table 1. Average Diameter (z-avg) and Polydispersity Index
(PdI) of Bare Nanogel or Nanomagnetogel (pegylated or not)
before and after DOTA Coupling
material z-avg (nm) PdI
dex 23.9 ± 0.423 0.388 ± 0.007
DOTAdex 25.3 ± 0.140 0.341 ± 0.006
dexPEG 32.4 ± 0.760 0.442 ± 0.014
DOTAdexPEG 37.1 ± 0.534 0.275 ± 0.017
dex_SPION 111.5 ± 2.368 0.197 ± 0.007
dexPEG_SPION 113.7 ± 1.227 0.197 ± 0.010
DOTAdex_SPION 111.7 ± 1.952 0.227 ± 0.015
DOTAdexPEG_SPION 110.5 ± 0.777 0.215 ± 0.005
Scheme 1. Schematics of the 111In-Labeled Nanomagnetogel
(pegylated)
Table 2. Longitudinal (r1) and Transverse (r2) Relaxivities
(25 °C, 0.47 T, 20 MHz) of dex_SPION and dexPEG_SPION
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loaded nanomagnetogels (Figure 1). For longer periods few
diﬀerences are observed among the formulations regarding blood
levels. Fitting the blood retention to a monoexponential decay
model aﬀords a blood half-life of approximately 4 h for all 111In-
labeled formulations.
The uptake of 111In-labeled nanogels or nanomagnetogels in
diﬀerent organs was evaluated and expressed as the fraction of
injected dose per gram of tissue (%ID/g). Figure 2 shows that the
unloaded [111In]DOTAdex generally presented signiﬁcantly
lower uptake in the liver, spleen, and kidneys than the loaded
counterpart. A signiﬁcant lower uptake was observed for the
pegylated nanomagnetogels, in the spleen, up to 72 h after
administration, when compared with unpegylated formulations.
In the liver, the uptake is inferior for pegylated nanomagnetogels,
but only in the initial 24 h, reaching after this period of time
similar values of unpegylated formulations.
In Vivo SPECT and MRI Imaging. Figure 3 shows the
sagittal SPECT images of mice injected with the diﬀerent
formulations at diﬀerent time points after administration.
SPECT images were in agreement with the results of the ex
vivo biodistribution studies. Highest levels of activity were found
in the bladder at 1 h after injection, which can be assigned to
residual free 111In or smaller 111In-labeled nanogels cleared
Figure 1. Retention of [111In]DOTAdex, [111In]DOTAdexSPION, or
[111In]DOTAdexPEG_SPION over 72 h in mice plasma. Bars represent
mean ± standard error of the mean of the %ID/g (n = 5). * p < 0.001
when compared to [111In]DOTAdex, # p < 0.001 when compared to
[111In]DOTAdexSPION.
Figure 2. Biodistribution values of [111In]DOTAdex, [111In]DOTAdexSPION, and [111In]DOTAdexPEG_SPION in main excretory organs over a
period of 72 h. Bars represent mean± standard error of the mean of the %ID/g (n = 5). * p < 0.05 when compared to [111In]DOTAdex, # p < 0.05 when
compared to [111In]DOTAdexSPION.
Figure 3. Sagittal SPECT images of three mice acquired at diﬀerent time
points after i.v. injection of (A) [111In]DOTAdex, (B) [111In]-
DOTAdexSPION, and (C) [111In]DOTAdexPEG_SPION. Color
intensity scale is denoted as white > red > yellow > green > blue. The
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mainly through the urinary system. At later time points, the
activity is mainly located in the liver and spleen (yellow and
orange arrows in Figure 3). As expected and in accordance with
the biodistribution studies, higher spleen labeling was observed
in the mouse injected with unpegylated nanomagnetogels
[111In]DOTAdexSPION. In addition, the SPECT images
showed that at 1 h after the tracer injection only 20% ± 1% of
the injected dose remains in the animal, indicating that all tracers
have a rapid clearance in the ﬁrst hour mainly through the
kidneys/bladder. At the end of the last scans, 72 h after tracer
injection, only 4% ± 0.48% of the injected dose remained in the
body.
We further used two mice to evaluate the in vivo MRI imaging
(Figure 4). Each animal was intravenously injected with either
DOTAdexSPION or DOTAdexPEG_SPION. At 15 min and 48
h post-injection, both formulations showed an increase in relative
contrast in the liver and spleen.
This preliminary imaging study seems to be in agreement with
the results of the ex vivo biodistribution study where is observed a
lower initial uptake in the liver for pegylated formulations and a
continuous uptake. Nonetheless, further animal studies should
be pursued in order to further access the potential of these
nanomagnetogels as MRI contrast agents.
Nanomagmetogel Stability (in Vivo). The stability of the
nanomagnetogel after intravenous administration is essential for
its biomedical use. To evaluate the nanomagnetogel stability, the
iron concentration (physically loaded through hydrophobic
interactions) in the spleen (whole organ) was quantiﬁed by ICP,
48 h post-injection, and correlated with the polymer
quantiﬁcation performed by scintigraphy (%ID/g).
The ICP measurements (Figure 5) demonstrate a good
correlation between the amount of polymer (expressed as %ID/
g) and the amount of iron (quantiﬁed by ICP). It should be
noted that this is a correlation between two parameters
quantiﬁed through diﬀerent techniques in a biological sample;
therefore, we assume a good correlation.
■ DISCUSSION
Particle size and surface properties (chemical structure, func-
tional groups, and charge) play an important role in the in vivo
behavior of nanogels. Variation of these parameters can strongly
aﬀect their fate in vivo. Modiﬁcation of the nanomagnetogel with
PEG is expected to modulate its interaction with proteins and
cells. The PEG hydrophilic coronamay avoid or at least minimize
the recognition and uptake of the nanosystem by the organs of
the mononuclear phagocytic system, thus increasing its blood
circulation time.16,17 Grafting of the dextrin backbone with
DOTA-monoamide type chelators was used to label nanogels
with a radioactive metal ion (e.g., 111In3+) for biodistribution and
imaging studies. The DOTA-monoamide type chelator forms an
overall neutral chelate with 111In3+. As a result, the labeling
procedure does not change the overall (neutral) charge of the
original (unlabeled) nanomagnetogel and therefore is not
Figure 4.MRI image analysis of mice injected with (A) DOTAdexSPION and (B) DOTAdexPEG_SPION. Images were taken before administration
(left), 15 min post-injection (middle) and 48 h post-injection (right). The percentage of increase in tissue contrast of mice injected with (C)
DOTAdexSPION and (D) DOTAdexPEG_SPION, calculated in the T2-weighted images relative to T = 0, deﬁned as the ratio of gray intensity in the
tissue of interest relative to the vertebrae in the same slide.15
Figure 5. Correlation between the uptake values (%ID/g) of (○)
[111In]DOTAdexSPION or (•) [111In]DOTAdexPEG_SPION and the
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expected to substantially aﬀect its biodistribution.6Moreover, the
DOTA scaﬀold forms exceptionally thermodynamically stable
and kinetically inert complexes with a range of metal ions (Gd3+
for MRI, 111In3+ for SPECT, 90Y3+ for therapy, 68Ga3+ for PET).18
The M(DOTA) complexes are so stable (log K In(DOTA) =
23.9) that their stability does not compromise their in vivo
applications.19,20
Numerous experimental and clinical studies have shown that,
after tumor accumulation, the use of high relaxivity contrast
agents results in improved detection and delineation of tumors
allowing a more reliable diagnosis.21 SPION are generally used as
T2 (negative)MRI contrast agents.
22,23 Higher relaxivity contrast
agents induce equivalent shortening of the relaxation times (T1,2)
of the water protons of tissues at lower doses, thus allowing
reduction of the doses, and so minimizing potential side eﬀects.
The nanomagnetogels described in this work, dexSPION and
dexPEG_SPION, are promising T2 contrast agents owing to
their r2 values and r2/r1 ratio, higher than those displayed by
other commercial Fe2O3 nanoparticulate contrast agents. The
magnetic properties were not signiﬁcantly aﬀected by the
introduction of PEG chains on the nanomagnetogel surface.
The TEM images demonstrate that nanomagnetogels comprise
clusters of magnetic iron oxide nanoparticles that should be
coupled to the alkyl chains within hydrophobic domains (Figure
S4, Supporting Information).
The obtained blood clearance proﬁles are clearly diﬀerent
from free [111In] or [111In]DOTA which are known to clear
almost entirely from the bloodstream within 30 min post-
injection.24 The smaller unloaded [111In]DOTAdex nanogel
showed signiﬁcantly higher blood levels 1 h after injection, as
compared to the larger nanomagnetogels. However, at longer
periods no signiﬁcant diﬀerences appear between formulations
regarding blood levels. Fitting the blood retention to a
monoexponential decay model aﬀords a blood half-life of
approximately 4 h, which is much longer than the commercially
available SPIONs such as Resovist (5 min)15 and Endorem (6
min).25 Nanoparticulate systems displaying hydrophobic
surfaces are readily opsonized resulting in eﬃcient uptake by
themononuclear phagocytic system and fast blood clearance. For
these systems, PEGylation often results in enhancement of
plasma lifetime, due to strong inhibition of the opsonization
mechanisms. Sugars and polysacharides have been reported to
display anti-adhesive properties similar to PEG. Thus, the
addition of PEG chains to the already hydrophilic polysaccharide
backbone, as in this work, can only produce a minor eﬀect on the
plasma lifetime.
The uptake proﬁles in the liver, spleen, and kidneys showed
lower uptake of unloaded nanogel than nanomagnetogels. Since
the unloaded nanogel is substantially smaller (∼30 nm) than the
loaded nanomagnetogel (∼110 nm), these results may be due to
an eﬀect of particle size on the biodistribution proﬁle.26 The
uptake of pegylated nanomagnetogels was found to be
signiﬁcantly lower in the spleen at all times, when compared to
unpegylated formulations. The SPECT imaging study revealed
good agreement with ex vivo results, such as accumulation in the
liver and spleen and higher levels of activity in the spleen of
mouse injected with unpegylated nanomagnetogels when
compared with pegylated formulations. MRI images also
revealed improved tissue contrast using pegylated nano-
magnetogel.
The stability of the nanomagnetogel, after intravenous
administration, is essential for its biomedical application. The
nanosystem needs a period of circulation in the bloodstream
without release of the iron particles to allow the carrier system to
reach the target. To further check whether the nanomagnetogels
remain stable during the biodistribution process, the amount of
elemental iron in the spleen (whole organ) was also analyzed by
ICP. A good correlation between the amount of polymer
(expressed as %ID/g) and the amount of iron (quantiﬁed by
ICP) was obtained indicating the colocalization of SPIONs with
the labeled polymer, i.e., the absence of leakage of iron from the
nanogels, after intravenous administration, suggesting high
stability of the nanomagnetogels in vivo.
■ CONCLUSION
The in vivo study of dextrin nanomagnetogels demonstrated
high stability after intravenous administration in a mice model, a
remarkable result taking in account the self-assembling
organization of the material. The amount of elemental iron in
the spleen (ICP analysis) presented a good correlation with the
amount of polymer (radioactivity quantiﬁcation), indicating the
absence of leakage of iron from the polymeric matrix. Therefore,
the proposed formulation allows a stable and safe iron transport
through the bloodstream without release of the iron particles,
allowing proper targeting and avoiding toxicity eﬀects. Regarding
the biodistribution proﬁle, pegylated nanomagnetogels resulted
in a signiﬁcant reduction of spleen accumulation. The blood half-
life obtained was approximately 4 h for all formulations, which is
a much longer circulation time than any commercially available
SPION such as Resovist (5 min) and Endorem (6min). The next
step would be the evaluation of tumor accumulation using
xenograft models and eventually exploring an active targeting
strategy.
■ EXPERIMENTAL SECTION
Materials. Dextrin-VA (dexVA) and dextrin-VA-SC16
(dexC16) were synthesized as described before.
27 DexVA consists
of a dextrin backbone (Glc(α1 → 6)Glc) with grafted acrylate
ester groups (VAvinyl group). DexC16 is composed by the
hydrophilic dextrin backbone with grafted VA groups, which are
partially substituted with long alkyl chains (SC16). In this work,
dexC16 with 30 vinyl groups (DSVA 30%) and 4.5 hexadecane-
thiol chains (DSSC16 4.5%) per 100 dextrin glucopyranoside
residues was used. O-[2-(3-Mercaptopropionylamino)ethyl]-O-
methylpolyethylene glycol 5000 (PEG-SH), dimethyl sulfoxide
(DMSO), and triethylamine (TEA) were purchased from
Aldrich. Solvents used were of reagent grade and puriﬁed by
usual methods. [111In]Cl3 was purchased from Covidien. Instant
thin layer chromatography silica gel impregnated glass ﬁber
(ITLC-SG) strips were purchased from Pall Life Science. ω-
Thiol functionalized metal chelator was synthesized according to
Scheme S1 presented and described in the Supporting
Information.
Preparation of DOTAdex and DOTAdexPEG. In the ﬁrst
step, dexVA was reacted with the ω-thiol functionalized metal
chelator to aﬀord the metal chelator grafted material. In the
second step, hexadecanethiol was added to the former material to
aﬀord the DOTAdex material. Finally, a thiol functionalized PEG
molecule (O-[2-(3-mercaptopropionylamino)ethyl]-O′-methyl-
polyethylene glycol 5000) was added to produce the
DOTAdexPEG material. Brieﬂy, dexVA (100 mg, DSVA 30%,
164 μmol equivalent VA) was dissolved in DMSO (3.7 mL). To
this solution ω-thiol functionalized metal chelator (63 mg, 121
μmol, 74% mol to VA groups) and triethylamine (64 μL, 462
μmol, 2.8 mol equiv to VA groups) were added. Themediumwas
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stirred for 72 h at room temperature. The mixture was dialyzed
(molecular weight cutoﬀ 1000) for 48 h against water, with
frequent water changes. After freeze-drying, a white candyﬂoss-
like material was obtained and stored at room temperature. The
number of DOTA groups attached to the polymer backbone was
estimated (0.0735 μmol/mg dry material) by back-titration of
excess (uncomplexed) In3+ with EDTA in the presence of the
complexometric indicator, xylenol orange, following incubation
of the metal derivatized polyssacharide with excess In3+. In the
second step grafting of 1-hexadecanethiol to the metal chelator
derivatized material was performed as previously reported.27
Brieﬂy, 100 mg of material was dissolved in DMSO (3.7 mL). To
this solution, hexadecanethiol (30 mg, 116 μmol, 71% relatively
to initial VA groups) and triethylamine (21 μL, 152 μmol, 0.9
mol equivalent to VA groups), were added. The medium was
stirred for 48 h, at 50 °C, and then dialyzed for 48 h against water,
with frequent water changes. After freeze-drying, DOTAdex was
obtained as a white candyﬂoss-like material and stored at room
temperature. DOTAdexPEG was obtained by performing the
Michael addition of thiolated-PEG (PEG-SH) to the function-
alized dextrin (DOTAdex), as previously reported.6 Brieﬂy,
DOTAdex (30 mg) and PEG-SH (25 mg, 5 μmol) were
dissolved in DMSO (0.350 mL) and triethylamine (2.5 μL, 18
μmol) was added. The mixture was stirred for 48 h, at 50 °C, and
then dialyzed for 48 h against water, with frequent water changes.
After freeze-drying, DOTAdexPEG was obtained as a white
candyﬂoss-like material and stored at room temperature.
Nanomagnetogel Preparation. The nanogel was obtained
by polymer dispersion (lyophilized powder) in distilled water
(2.0 mg/mL), under stirring at 50 °C, until a clear colloidal
suspension was obtained. The dispersion was then ﬁltered
through a 0.22 μm syringe ﬁlter. Self-assembly of the polymer
generates nanostructures that are stabilized by hydrophobic
domains28 and enable the solubilization of hydrophobic
molecules.29 Bare γ-Fe2O3 nanoparticles were prepared as
previously published.30 Brieﬂy, the ﬁrst step is to add
dimethylamine ((CH3)2NH) to an aqueous micellar solution
of ferrous dodecyl sulfate (Fe(DS)2). The ﬁnal concentrations
after mixing of the reactants are 1.3 × 10−2 M and 8.5 × 10−1 M
for Fe(DS)2 and (CH3)2NH, respectively. The solution is stirred
vigorously for 2 h at 28.5 °C and the resulting precipitate of
uncoated nanocrystals is isolated from the supernatant by
centrifugation. In the second step, this precipitate is washed with
an acidic solution at pH 2 (HCl 10−1 M). γ-Fe2O3 nanoparticles
were loaded into the hydrophobic nanodomains within dextrin
nanogel, dispersed in distilled water. The physical entrapment of
γ-Fe2O3 into the nanogel was performed following the nanogel
preparation procedure, as described above. The required volume
of 10 mM γ-Fe2O3 stock solution was added to the nanogel
dispersion and the pH of the dispersion was adjusted to 7.4 using
HCl solution 0.05 M. The formulation stirred overnight to allow
γ-Fe2O3 incorporation into the nanogel. After that, formulations
were centrifuged at 4000 g for 10 min (room temperature) to
remove free γ-Fe2O3. The produced nanomagnetogel contains
4.0 mM of iron (determined by atomic absorption spectroscopy)
and is stable for at least 8 weeks, water dispersion at 4 °C, as
previously evaluated by analyzing the size distribution (intensity-
weighted diameter).11
Nanomagnetogel Characterization. Size Distribution
and Zeta Potential. The size distribution and zeta potential of
nanogels were determined by dynamic light scattering (DLS)
with a Malvern Zetasizer, NANO ZS (Malvern Instruments
Limited, UK), using a He−Ne laser (wavelength of 633 nm) and
a detector angle of 173°. The nanomagnetogel dispersion (1mL)
was analyzed at 25 °C. The DLS analysis provides the
characterization of a sample through the mean value (z-average)
for the size and a width parameter known as polydispersity or
polydispersity Index (PdI). The z-average diameter is the mean
hydrodynamic diameter, determined from the intensity of
scattered light, which can be converted to other distributions.
In the present work, the z-average based on the intensity of
scattered light is considered the best approach to the actual size.
Nanomagnetogel dispersion was analyzed in a polystyrene cell or
in a folded capillary cell, for size distribution or zeta potential
measurements, respectively. The zeta potential values were
calculated using the Smoluchowski equation.31
Relaxometry. Magnetic resonance relaxometry was used to
measure the longitudinal (T1) and transverse (T2) proton
relaxation times for the nanomagnetogel. Measurements were
performed using a Bruker Minispec mq20 relaxometer operating
at a magnetic ﬁeld of 0.47 T, corresponding to a Larmor
frequency of 20 MHz, and at a temperature of 25 °C. T1 and T2
relaxation times were obtained using the inversion−recovery
(IR) and Carr−Purcell−Meiboom−Gill (CPMG) pulse sequen-
ces, respectively. The reproducibility of the relaxation time
determinations was found to be better than ±1%. The
corresponding relaxivity values, r1 and r2, were calculated
through the least-squares curve ﬁtting of 1/T1,2 = R1,2 (s
−1)
versus the iron concentration (mM Fe).
Preparation of Radiolabeled Materials. To a dispersion
of DOTAdex, DOTAdex_SPION, or DOTAdexPEG_SPION in
water (1.0 mg in 500 μL), 100 μL of ammonium acetate (pH 5.5)
and [111InCl3] (100 MBq in 100 μL) were added. The labeling
mixture was incubated at 50 °C for 2 h in a thermomixer (400
rpm). The labeling was followed by thin layer chromatography
using silica gel strips (ITLC-SG) developed with 0.1 M
ammonium acetate (pH 5.5)/0.1 M EDTA (1:1, v/v) as the
eluent to determine the percentage of free [111In] ([111In] is used
to represent the [111In3+] species). TLC strips were analyzed with
a TLCVCS-103 radiochromatograph scanner. [111In]DOTAdex,
[111In]DOTAdex_SPION, or [111In]DOTAdexPEG_SPION
remained at the origin, whereas free [111In]Cl3 migrates with a
Rf of 0.8−0.9. The labeling eﬃciency was 45%, 80%, and 98% for
[111In]DOTAdex, [111In]DOTAdex_SPION, or [111In]-
DOTAdexPEG_SPION, respectively. Each compound was
puriﬁed by centrifugation, through a Vivaspin 10 kDa, and
washed twice with 2 mL of a PBS (pH 7.4)/EDTA (1.25 mg/
mL) solution to remove the free [111In] as [111In]-EDTA
complex. The products were then dissolved in PBS (pH 7.4) to
prepare appropriate doses for biodistribution and imaging
studies.
Biodistribution Studies. Biodistribution was studied in
BALB/c mice (7 weeks of age, 23−28 g body weight, Harlan). All
animals were housed under standard environmental conditions
(free access to food and water and a 12/12 h light/dark cycle),
and acclimatized for at least 1 week after arrival before the
experiment was started. All animal experiments were approved
by the Institutional Animal Care and Use Committee of the
University of Groningen and carried out according to the Dutch
laws and regulations for animal experiments. The animals were
divided in groups of 5 animals and injected with 0.5−2.0 mBq
(0.1−0.15 mL) of 111In-labeled nanogel or nanomagnetogel
preparation via the penile vein. Mice were sacriﬁced by cervical
dislocation 1, 6, 24, 48, or 72 h after injection. A blood sample
was taken, and tissues of interest were dissected, weighed, and
counted in a gamma counter. The uptake of 111In-labeled
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nanogels in various organs was measured in counts per minute
(CPM), corrected for radioactive decay, for the counting
eﬃciency of the gamma counter, injected dose, and body weight
of the animal. Tissue distribution was expressed as percent
injected dose per gram of tissue (%ID/g). The plasma uptake
values were used to ﬁt a monoexponential decay function to
determine the blood circulation half-life.
SPECT Imaging. Longitudinal imaging was carried out in
BALB/c mice. The animals were injected in the penile vein with
12−20 MBq (0.1−0.15 mL) of 111In-labeled formulations:
[111In]DOTAdex, [111In]DOTAdexSPION, and [111In]-
DOTAdexPEG_SPION. The animals were anesthetized with
1.5% isoﬂuorane in medical air and positioned in the U-SPECT-
II (MILabs) equipped with a mouse multipinhole collimator (0.6
mm diameter). Static whole body tomographic images were
acquired for 60 min immediately after tracer injection and at 5,
23, 47, and 71 h after tracer injection. Once the scan at 72 h was
completed, the animals were sacriﬁced by cervical dislocation. A
20% main photopeak was centered at 171 and 245 keV to
reconstruct the 111In images on 0.1875 mm voxels by 2 iterations
of 16 subsets (ordered subsets expectation maximization,
OSEM). To evaluate the whole-body clearance over time, a
region of interest (ROI) was created over the whole body image,
at all time points, and compared to the values in the ﬁrst 10 min
of each scan.
MRI Imaging. A vertical 9.4 T and 89-mm-diameter bore MRI
scanner equipped with a 1500 mT/m gradient set (Bruker
Biospin GmbH, Ettlingen, Germany) was used to study the
uptake of magnetic particles in the liver and spleen. Mice were
anesthetized with 1.5−3.0 vol % isoﬂurane in a 2:1 mixture of
medical air and oxygen. The mice were put on a custom-built
cradle and positioned inside a 3-cm-diameter quadrature volume
coil. For cardiac triggering, both cardiac and respiratory motion
signals were monitored by a pressure pad placed under the chest
of the mouse. After global shimming and RF pulse calibration,
scout scans were made to plan 6 short-axis slices through the liver
and spleen. The short-axis T2-weighted MR images were
obtained with a fast spin echo with fat suppression. Imaging
parameters were as follows: repetition time = 2800ms; echo time
= 3.95ms, eﬀective echo time = 27.65ms with a turbo factor = 20,
number of averages = 16; ﬁeld of view = 25.3× 25.3; matrix size =
300× 300, in plane resolution = 84× 84 umwith a slice thickness
= 1mm; the total acquisition time was 8min. Themice were then
intravenously injected with DOTAdexSPION (2.84 mg [Fe]/kg
body weight) or DOTAdexPEG_SPION (3.44 mg [Fe]/kg
body weight). MRI scans were acquired 15 min and 48 h after
injection of the formulations. Regions of interest (ROI) were
drawn in the selected organs (spleen, liver, and vertebra) and
gray scale intensity was measured. The signal-to-noise ratios
(SNR) was plotted against time according to the following
equations:
=SNR gray intensity mean value in ROI/ROI mean value 





[1 (SNR at time )]/(SNR at time zero before 
contrast) 100 (3)
ICP-MS Analysis. The ICP assays were performed by the
Pharmacy laboratories of the University Medical Centre
Groningen. Brieﬂy, spleen samples obtained in the biodistribu-
tion study at 48 h post-injection were used for the inductively
coupled plasma-mass spectrometry (ICP-MS). The sample
matrices were diluted and destroyed in an argon torch of at
least 600 °C. The relevant elements remaining in solution were
ionized and measured in the mass spectrometer. The measured
iron concentrations in the samples were normalized to an ICP-
MS iron standard.
Statistical Analysis. Diﬀerences tissue uptake (%ID/g) and
circulation half-life (hours) between groups were analyzed by
two-way analysis of variance (ANOVA) with a Bonferroni
posthoc test to correct for multiple comparisons using the Prism
v 5 software package (GraphPad, San Diego, CA).
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